more_reports

The Latest Healthcare Services Articles from Streetwise Reports

AI Study Tracks Unexpected Cognitive Gains in Vascular Dementia Trial

  ()
Hemostemix Inc.'s (HEM:TSXV; HMTXF:OTCQB; 2VF0:FSE) Phase 1 trial, in collaboration with Firefly Neuroscience Inc. (AIFF:NASDAQ), is evaluating ACP-01s impact on vascular dementia using AI-driven brain analysis. Early insights could reshape treatment approaches.
Tags: Healthcare Services

Canadian Healthcare Co. Showcases Stable FQ424

Research Report
  ()
Leede Financial Inc. raised its target price on CareRX Corp. (CRRX:TSX; CHHHF:OTCMKTS). Read on to see why one Leede analyst rates the stock as a Buy.
Tags: Biotechnology / PharmaceuticalsHealthcare Services

Virtual Healthcare Breakthrough Expanding Access for 6.9M Medicaid Patients in New York

  ()
Rocket Doctor, under Treatment.com AI Inc. (TRUE:CSE; TREIF:OTCMKTS; 939:FRA), is now an in-network provider for New York Medicaid, expanding virtual healthcare access to 6.9 million beneficiaries. Find out how this milestone offers the possibility to reshape healthcare accessibility.
Tags: Healthcare Services

Healthcare Tech Co. To Acquire Digital Health Platform

  ()
This will expand its ecosystem of AI-powered products. Read on to learn more about its offerings and rapidly growing sector.
Tags: Healthcare Services

Kentucky Medical Co. Has Strong Operating Fundamentals

Research Report
  ()
Quipt Home Medical Corp. (QIPT:NASDAQ; QIPT:TSX.V) received a lowered price target but a Buy rating from a Leede Financial Inc. research note.
Tags: Healthcare ServicesMedical Devices

New Strategic Moves Aim To Accelerate Growth in AI Healthcare

  ()
Light AI Inc. (ALGO:CBOE) announces major marketing campaigns, advisory board appointments, and a key regulatory partnership to drive growth. Discover how these strategic moves could shape the future of AI healthcare.
Tags: Healthcare ServicesTechnology

Should You Double Down on This Story Stock?

Contributed Opinion
  ()
Chris Temple of The National Investor explains why he believes you might want to double down on BioLargo Inc. (BLGO:OTCQX).
Tags: Medical DevicesHealthcare Services

Is This Centrally Positioned AI Healthcare Co. Set to Transform the Industry?

Contributed Opinion
  ()
Technical Analyst Clive Maund explains why he thinks Treatment.com AI Inc. (TRUE:CSE; TREIF:OTCMKTS; 939:FRA) offers potential upside to investors.
Tags: Healthcare ServicesLife Sciences Tools & Diagnostics

New Quebec Law Affecting Healthcare Co.'s Bottom Line

Research Report
  ()
Quebec-based staffing operator Premier Health of America Inc. (PHA:TSX.V) reported soft financial data for the fourth quarter of 2024 as the province's Bill 10 act limiting the use of per diem operations. Find out why this analyst thinks things will improve for the company.
Tags: Healthcare Services

Revolutionary AI Tools Take Center Stage in Medical Education Symposium

  ()
Treatment.com AI Inc. (TRUE:CSE; TREIF:OTCMKTS; 939:FRA) has announced the release of its newly updated Medical Education Suite (MES). Read more to find out how this update is set to transform medical education and enhance training efficiency.
Tags: Healthcare ServicesMedical Devices

Medical Co. Ready for a Transformative F2025

Research Report
  ()
The Leede Financial Inc. analyst also noted that while F2024 is a transition year for Profound Medical Corp. (PROF:NASDAQ; PRN:TSX), F2025 is expected to be transformative for U.S. TULSA-PRO adoption. rates.
Tags: Healthcare ServicesMedical Devices

AI Healthcare Co. With 'Bright' Outlook Closes Placement

  ()
Healthcare artificial intelligence (AI) company Treatment.com AI Inc. (TRUE:CSE; TREIF:OTCMKTS; 939:FRA) has closed a non-brokered private placement for aggregate gross proceeds of CA$1.95 million. Find out why one analyst says the stock is a Strong Buy and worth going overweight on.
Tags: Life Sciences Tools & DiagnosticsHealthcare ServicesTechnology

Is This AI Healthcare Stock Worth Being Overweight On?

Contributed Opinion
  ()
Technical Analyst Clive Maund explains why he thinks Treatment.com AI Inc. (TRUE:CSE; TREIF:OTCMKTS; 939:FRA) is a Strong Buy and worth being overweight on.
Tags: Healthcare ServicesTechnologyLife Sciences Tools & Diagnostics

AI Collaboration to Streamline Healthcare Administration and Improve Patient Outcomes

  ()
Treatment.com AI Inc. (TRUE:CSE; TREIF:OTCMKTS; 939:FRA) has formally entered a collaborative agreement with UK-based AI healthcare technology company SPRYT Limited. Read how this partnership aims to change the way patients interact with their healthcare providers.
Tags: Healthcare Services

Showing Results: 1 to 14 of 14